Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen, replacing the usual study record content with an access-denied notice.
    Difference
    22%
    Check dated 2026-09-19T22:26:46.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, signaling a small backend or content update.
    Difference
    0.0%
    Check dated 2026-08-29T18:49:51.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added to the page, indicating an update to the study record. A large set of core trial details, including the listed interventions (Nivolumab, Losartan, FOLFIRINOX) and related MeSH terms, were removed from the study record, altering the displayed scope of the trial.
    Difference
    21%
    Check dated 2026-08-08T19:26:48.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added, replacing the previous Revision: v3.6.3 in the page's study record dates.
    Difference
    0.0%
    Check dated 2026-07-25T11:38:46.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    No changes were recorded for this page. The study overview, design, and eligibility criteria remain as published.
    Difference
    0.0%
    Check dated 2026-07-18T05:18:28.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The study record revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. The change reflects an incremental update to the publicly posted record rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-03T22:16:59.000Z thumbnail image

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.